Literature DB >> 1906035

Characterization of cDNAs encoding the polypyrimidine tract-binding protein.

A Gil1, P A Sharp, S F Jamison, M A Garcia-Blanco.   

Abstract

The polypyrimidine tract of mammalian introns is recognized by a 62-kD protein (pPTB). Mutations in the polypyrimidine tract that reduce the binding of pPTB also reduce the efficiency of formation of the pre-spliceosome complex containing U2 snRNP. The PTB protein was purified to homogeneity by affinity chromatography on a matrix containing poly(U), and peptide sequence was used to isolate several cDNAs. Because a variety of cell types express mRNA complementary to these cDNAs, PTB may be a ubiquitous splicing factor. Three classes of cDNAs were identified, on the basis of the presence of additional sequences at an internal position. This variation in sequence probably reflects alternative splicing of the PTB pre-mRNA and produces mRNAs encoding the prototype PTB protein, a form of PTB protein containing 19 additional residues, and a truncated form of PTB protein with a novel carboxyl terminus. A murine homolog of pPTB has been characterized previously as a DNA-binding protein. Sequence comparisons indicate that pPTB is distantly related to the hnRNP L protein and that these two proteins should be considered as members of a novel family of RNA-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906035     DOI: 10.1101/gad.5.7.1224

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  117 in total

1.  Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C(pro).

Authors:  Sung Hoon Back; Yoon Ki Kim; Woo Jae Kim; Sungchan Cho; Hoe Rang Oh; Jung-Eun Kim; Sung Key Jang
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 2.  Polypyrimidine tract binding protein antagonizes exon definition.

Authors:  E J Wagner; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

3.  A novel conserved RNA-binding domain protein, RBD-1, is essential for ribosome biogenesis.

Authors:  Petra Björk; Göran Baurén; ShaoBo Jin; Yong-Guang Tong; Thomas R Bürglin; Ulf Hellman; Lars Wieslander
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

4.  Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2).

Authors:  Y Hofmann; C L Lorson; S Stamm; E J Androphy; B Wirth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

5.  Interaction of hnRNP A1 with snRNPs and pre-mRNAs: evidence for a possible role of A1 RNA annealing activity in the first steps of spliceosome assembly.

Authors:  M Buvoli; F Cobianchi; S Riva
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

6.  The spliceosome assembly pathway in mammalian extracts.

Authors:  S F Jamison; A Crow; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

7.  The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms.

Authors:  A Moreira; Y Takagaki; S Brackenridge; M Wollerton; J L Manley; N J Proudfoot
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

8.  Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements.

Authors:  A C Black; J Luo; C Watanabe; S Chun; A Bakker; J K Fraser; J P Morgan; J D Rosenblatt
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  A human NDP-kinase B specifically binds single-stranded poly-pyrimidine sequences.

Authors:  M Hildebrandt; M L Lacombe; S Mesnildrey; M Véron
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

10.  Cell proteins bind to a linear polypyrimidine-rich sequence within the 5'-untranslated region of rhinovirus 14 RNA.

Authors:  I A Rojas-Eisenring; M Cajero-Juarez; R M del Angel
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.